Literature DB >> 17025023

Chronic allograft nephropathy--immunologic and nonimmunologic factors.

Mirosław Banasik1, Marian Klinger.   

Abstract

Chronic Allograft Nephropathy (CAN) is one of the most common cause of kidney transplant loss. CAN may be caused by immunologic as well as nonimmunologic factors which may interfere and increase response. Immunologic factors include acute rejection, degree of HLA mismatch, inadequate immunosuppression. Nonimmunologic factors contain delayed graft function, ischemia-reperfusion injury, nephrotoxicity of calcineurin inhibitors, hyperfiltration, hypertension and hyperlipidemia. The histopatological description of CAN may indicate two phases of injury. An initial phase by one year include tubulointerstitial infiltration in the late phase of CAN arteriolar hyalinosis and glomerulosclerosis were revealed. Modification of the immunosuppressive treatment with reduction or withdrawal of calcineurin inhibitors may prevent graft loss, while addition of nonnephrotoxic agents such as mycophenolate mofetil or sirolimus should be considered by the risk of acute rejection. Additionally effective management by hypertension and hyperlipidemia is essential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025023

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  5 in total

1.  Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.

Authors:  F Favreau; R Thuillier; J Cau; S Milin; E Manguy; G Mauco; X Zhu; L O Lerman; T Hauet
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

2.  Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.

Authors:  Sunil M Kurian; Raymond Heilman; Tony S Mondala; Aleksey Nakorchevsky; Johannes A Hewel; Daniel Campbell; Elizabeth H Robison; Lin Wang; Wen Lin; Lillian Gaber; Kim Solez; Hamid Shidban; Robert Mendez; Randolph L Schaffer; Jonathan S Fisher; Stuart M Flechner; Steve R Head; Steve Horvath; John R Yates; Christopher L Marsh; Daniel R Salomon
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

3.  Clinical Course and Outcomes of Late Kidney Allograft Dysfunction.

Authors:  Viktor Denisov; Vadym Zakharov; Anna Ksenofontova; Eugene Onishchenko; Tatyana Golubova; Sergey Kichatyi; Olga Zakharova
Journal:  J Transplant       Date:  2016-07-10

4.  Adherence to Immunosuppressive Therapies after Kidney Transplantation from a Biopsychosocial Perspective: A Cross-Sectional Study.

Authors:  Justyna Zachciał; Izabella Uchmanowicz; Magdalena Krajewska; Mirosław Banasik
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

5.  Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation.

Authors:  Ivana Stanimirova; Mirosław Banasik; Adam Ząbek; Tomasz Dawiskiba; Katarzyna Kościelska-Kasprzak; Wojciech Wojtowicz; Magdalena Krajewska; Dariusz Janczak; Piotr Młynarz
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.